MedPath
NMPA Approval

Lomefloxacin Aspartate Injection

国药准字H20056030

September 5, 2019

Drug Information

门冬氨酸洛美沙星注射液

注射剂

2ml: 0.1g (以C17H19F2N3O3计)

化学药品

September 5, 2019

Company Information

Applicant Company

Manufacturing Company

新郑市人民路北侧

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

门冬氨酸洛美沙星注射液 - NMPA 批准文号 | MedPath